Fridays Meds GLP 1

Product Details

What Is Fridays Meds GLP-1?

Fridays Meds GLP-1 is an online medical weight-management program that connects eligible adults with licensed healthcare providers. Depending on the provider’s assessment, the program may provide access to compounded semaglutide, compounded tirzepatide, or certain brand-name medications.

The program combines prescription management with virtual provider visits, nutrition guidance, mental health support, dietitian access, and ongoing coaching. A prescription is not guaranteed because the treating clinician determines whether a medication is medically appropriate for each individual.

Who May Consider Fridays Meds GLP-1?

Adults looking for medically supervised weight-management options may consider the Fridays program after completing its online health assessment. Medication selection depends on medical history, current health, medication use, and the provider’s clinical judgment.

Fridays states that participants must be at least 18 years old, while eligibility for a particular medication is determined during clinical review. People with ongoing medical concerns should discuss those conditions fully with their healthcare provider.

How May Fridays Meds GLP-1 Support Weight Management?

GLP-1 medications act on pathways involved in appetite, digestion, and metabolic regulation. Tirzepatide also acts on the GIP pathway. The exact medication and dose provided through Fridays depend on an individual clinical assessment.

The program also includes nutrition and lifestyle coaching alongside medical care. These services may help participants follow a structured weight-management plan while receiving ongoing clinical guidance.

Compounded medications should not be considered interchangeable with FDA-approved medicines. The FDA states that compounded semaglutide and tirzepatide do not undergo FDA premarket review for safety, effectiveness, or quality.

Medication Information

The Fridays program may provide compounded semaglutide or tirzepatide when a licensed provider considers appropriate.

• Compounded Semaglutide

Semaglutide is a GLP-1 receptor agonist. Fridays’ safety information describes its compounded injectable formulation as a once-weekly medication, with the specific dose and any dose adjustment determined by the prescribing provider.

• Compounded Tirzepatide

Tirzepatide acts on GLP-1 and GIP receptor pathways. Fridays describes its compounded formulation as a once-weekly subcutaneous injection, with dosing and possible adjustments directed by the healthcare provider.

Other Ingredients And Formulation Details

Inactive ingredients, concentrations, vial sizes, and formulation details may vary according to the medication prescribed and the dispensing pharmacy.

Patients should review the pharmacy-provided medication label for:

• Exact medication strength
• Prescribed dose
• Inactive ingredients
• Storage requirements
• Allergy information
• Beyond-use date
• Injection and administration instructions

Fridays notes that it does not manufacture compounded medications and that the medication received may differ in appearance and labeling from website images.

Potential Benefits

• May provide access to clinician-supervised GLP-1 treatment
• May support medically guided weight-management goals
• Provides ongoing virtual provider access
• Includes nutrition and lifestyle coaching
• Provides prescription management and journey support

Individual treatment outcomes vary, and receiving a prescription or achieving a particular amount of weight loss is not guaranteed.

Important Limitations

• Prescription approval depends on individual medical evaluation.
• Not every medication option is appropriate for every patient.
• Compounded medication formulation may differ between pharmacies.
• Treatment outcomes vary between individuals.
• Long-term treatment decisions require continued provider supervision.

The FDA advises that compounded GLP-1 drugs should generally be used when a patient’s medical needs cannot be met by an FDA-approved drug.

How To Use?

• Complete the Fridays health assessment and medical review before receiving medication.
• Use only the medication and dose prescribed by your healthcare provider.
• Fridays states that compounded injectable semaglutide and tirzepatide are generally administered subcutaneously once weekly.
• Injection sites may include the abdomen, thigh, or upper arm according to provider instructions.
• Do not increase, reduce, or stop your prescribed dose without discussing it with your provider.
• Follow the dispensing pharmacy’s instructions for storage and handling.

Warnings And Precautions

• Tell your provider about all prescription and over-the-counter medications, vitamins, and supplements.
• Do not combine GLP-1/GIP medications unless specifically directed by a qualified healthcare provider.
• Discuss any history of pancreatitis, kidney disease, diabetes, or serious gastrointestinal problems.
• Inform your provider of any personal or family history of medullary thyroid carcinoma or MEN 2.
• Compounded semaglutide or tirzepatide should not be used during pregnancy.
• Discuss breastfeeding or plans for pregnancy with the prescribing provider.
• Seek medical advice promptly for severe or persistent adverse reactions.
• Follow the exact dose and measuring instructions supplied with compounded injectable medication.

Possible Side Effects And Interactions

Common effects reported in Fridays’ safety information for compounded semaglutide and tirzepatide include nausea, vomiting, diarrhea, constipation, abdominal discomfort, reflux, headache, fatigue, dizziness, and injection-site reactions. More serious reactions can occur and require medical attention.

These medications can also affect gastric emptying and may influence absorption of some oral medicines. Diabetes medications such as insulin or sulfonylureas may require additional consideration. Patients should give their provider a complete medication and supplement list before treatment.

Pros

• Licensed-provider medical evaluation
• Semaglutide and tirzepatide options
• Unlimited provider visits on listed plans
• Nutrition and lifestyle support included
• Medication costs included with compounded plans

Cons

• Prescription eligibility is not guaranteed
• Possible gastrointestinal and other side effects
• Pricing depends on medication and billing plan
• Compounded formulations may vary by pharmacy

Pricing

Current Fridays pricing varies by medication, billing schedule, and any active promotional offer shown online.

• Semaglutide starts at: $117
• Tirzepatide starts at: $198

Listed compounded plans include medication costs, unlimited provider visits, group coaching, access to the SESH fitness app, and one-on-one dietitian and journey support. Fridays states that there are no separate membership, sign-up, or lab fees with these plans.

Pharmacist Note

Before beginning a GLP-1 medication, provide your clinician with a complete medication list and medical history. Follow the prescribed dose carefully, particularly with compounded injectable products, because incorrect measurement or rapid dose increases can raise the risk of adverse effects.

FAQ

1. What is Fridays Meds GLP-1?

Fridays Meds GLP-1 is a telehealth weight-management program offering clinician evaluation and potential access to compounded semaglutide, compounded tirzepatide, or selected brand-name medications when medically appropriate.

2. Does Fridays Meds GLP-1 require a prescription?

Yes. GLP-1 medications available through Fridays require evaluation by a licensed healthcare provider. The provider reviews medical information and determines whether prescribing a particular medication is appropriate.

3. How are the compounded GLP-1 injections taken?

Fridays states that compounded semaglutide and tirzepatide injections are generally given under the skin once weekly. The exact dose, injection instructions, and schedule come from the prescribing provider.

4. Are compounded Fridays GLP-1 medications FDA-approved?

No. Compounded semaglutide and tirzepatide are not FDA-approved. FDA-approved brand-name medications may also be available through the program, depending on clinical eligibility, prescription, insurance, and availability.

5. Are provider visits included with the program?

Yes. Fridays lists unlimited provider visits with its compounded GLP-1 plans, along with nutrition and mental health coaching, prescription support, dietitian guidance, and additional journey support.

6. What happens if I am not medically eligible?

Fridays states that if a licensed provider determines that a customer is medically ineligible before services begin, a refund may be available for that billing cycle under its refund policy.

Medical Disclaimer

This page is for general informational purposes and does not provide medical advice or replace evaluation by a licensed healthcare professional. Prescription medications should only be used as directed by the prescribing provider.

Compounded semaglutide and compounded tirzepatide are not FDA-approved, and the FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed. Discuss potential benefits, risks, contraindications, interactions, and alternatives with a qualified healthcare professional.

Sources And Product Review Information

• Official website: Fridays Meds GLP 1
• Fridays medication safety information
• Fridays FAQs and program information
• Fridays refund and cancellation policy
• U.S. Food and Drug Administration information on compounded GLP-1 medications

Affiliate Disclosure: This page may include affiliate links. We may earn a commission if you purchase through these links, at no extra cost to you. Our content remains independent and is based on publicly available product, label, and manufacturer information.